{"id":218,"date":"2008-02-01T12:28:29","date_gmt":"2008-02-01T17:28:29","guid":{"rendered":"http:\/\/blogs.law.harvard.edu\/politicshiv\/2008\/02\/01\/uganda-begins-production-of-9-per"},"modified":"2008-02-01T16:00:04","modified_gmt":"2008-02-01T21:00:04","slug":"uganda-begins-production-of-9-per-month-arvs","status":"publish","type":"post","link":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/2008\/02\/01\/uganda-begins-production-of-9-per-month-arvs\/","title":{"rendered":"Uganda begins production of $9 per month ARVs"},"content":{"rendered":"<p>From the <a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=50107\">KaiserNetwork.org<\/a><\/p>\n<p>A pharmaceutical plant in Uganda this week will begin production of generic antiretroviral drugs following an order from the Ugandan<br \/>\ngovernment for drugs worth 17 billion Ugandan shillings, or about $10 million, the <a href=\"http:\/\/www.busiweek.com\/index.php?option=com_content&amp;task=view&amp;id=4667&amp;Itemid=9\" target=\"_new\"><cite>East African Business Week<\/cite><\/a> reports (Etyang, <cite>East African Business Week<\/cite>, 1\/28).<br \/>\n<cite><br \/>\n<\/cite>Ugandan President Yoweri Museveni in October 2007 commissioned the 15-acre pharmaceutical plant, which will produce triple-therapy combination antiretroviral and first-line malaria treatments. Ugandan pharmaceutical importer Quality Chemical Industries and Indian<br \/>\npharmaceutical company <a href=\"http:\/\/www.cipla.com\/\" target=\"_new\">Cipla<\/a> will produce the drugs. The factory will manufacture the antiretroviral combination therapy Triomune, which contains lamivudine, stavudine and nevirapine. In addition, the factory will produce the first-line antimalarial combination treatment Lumartem, which contains artemisinin and lumefantrin (<a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?hint=1&amp;DR_ID=49019\" target=\"_new\"><cite>Kaiser Daily HIV\/AIDS Report<\/cite><\/a>, 11\/26\/07)&#8230;<\/p>\n<p>&#8230;According to the <cite>Business Week<\/cite>, about 100,000 Ugandans currently have access to no-cost antiretroviral treatment, but about<br \/>\n238,000 people in the country are expected to need the drugs by 2012. In 2005, about 42% of people in need of antiretrovirals had access to them, according to statistics (<cite>East African Business Week<\/cite>, 1\/28).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>From the KaiserNetwork.org A pharmaceutical plant in Uganda this week will begin production of generic antiretroviral drugs following an order from the Ugandan government for drugs worth 17 billion Ugandan shillings, or about $10 million, the East African Business Week reports (Etyang, East African Business Week, 1\/28). Ugandan President Yoweri Museveni in October 2007 commissioned [&hellip;]<\/p>\n","protected":false},"author":712,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-218","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/posts\/218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/users\/712"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/comments?post=218"}],"version-history":[{"count":0,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/posts\/218\/revisions"}],"wp:attachment":[{"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/media?parent=218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/categories?post=218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/politicshiv\/wp-json\/wp\/v2\/tags?post=218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}